Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence
Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicr...
Saved in:
Published in | Molecules (Basel, Switzerland) Vol. 26; no. 2; p. 444 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
16.01.2021
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed. |
---|---|
AbstractList | Magainin 2 (
), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of
play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of
are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of
derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide
stapling between the first and fifth position from the
-terminus showed higher antimicrobial activity than that of
against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides
and
in antimicrobial and hemolytic activity, electrophysiological measurements were performed. Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed. Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed.Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N-terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed. Magainin 2 ( Mag2 ), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity via microbial membrane disruption. It has been reported that the helicity and amphipathicity of Mag2 play important roles in its antimicrobial activity. We investigated and recently reported that 17 amino acid residues of Mag2 are required for its antimicrobial activity, and accordingly developed antimicrobial foldamers containing α,α-disubstituted amino acid residues. In this study, we further designed and synthesized a set of Mag2 derivatives bearing the hydrocarbon stapling side chain for helix stabilization. The preferred secondary structures, antimicrobial activities, and cell-membrane disruption activities of the synthesized peptides were evaluated. Our analyses revealed that hydrocarbon stapling strongly stabilized the helical structure of the peptides and enhanced their antimicrobial activity. Moreover, peptide 2 stapling between the first and fifth position from the N -terminus showed higher antimicrobial activity than that of Mag2 against both gram-positive and gram-negative bacteria without exerting significant hemolytic activity. To investigate the modes of action of tested peptides 2 and 8 in antimicrobial and hemolytic activity, electrophysiological measurements were performed. |
Author | Kawano, Ryuji Demizu, Yosuke Saito, Chihiro Yokoo, Hidetomo Misawa, Takashi Hirano, Motoharu Goto, Chihiro |
AuthorAffiliation | 3 Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-6 Naka-cho, Koganei, Tokyo 184-8588, Japan; c-saito@st.go.tuat.ac.jp (C.S.); rjkawano@cc.tuat.ac.jp (R.K.) 2 Graduate School of medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan 1 Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan; w205435g@yokohama-cu.ac.jp (M.H.); yokoo@nihs.go.jp (H.Y.); w195412a@yokohama-cu.ac.jp (C.G.) |
AuthorAffiliation_xml | – name: 1 Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki, Kanagawa 210-9501, Japan; w205435g@yokohama-cu.ac.jp (M.H.); yokoo@nihs.go.jp (H.Y.); w195412a@yokohama-cu.ac.jp (C.G.) – name: 3 Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-6 Naka-cho, Koganei, Tokyo 184-8588, Japan; c-saito@st.go.tuat.ac.jp (C.S.); rjkawano@cc.tuat.ac.jp (R.K.) – name: 2 Graduate School of medical Life Science, Yokohama City University, 1-7-29, Yokohama, Kanagawa 230-0045, Japan |
Author_xml | – sequence: 1 givenname: Motoharu surname: Hirano fullname: Hirano, Motoharu – sequence: 2 givenname: Chihiro surname: Saito fullname: Saito, Chihiro – sequence: 3 givenname: Hidetomo surname: Yokoo fullname: Yokoo, Hidetomo – sequence: 4 givenname: Chihiro surname: Goto fullname: Goto, Chihiro – sequence: 5 givenname: Ryuji orcidid: 0000-0001-6523-0649 surname: Kawano fullname: Kawano, Ryuji – sequence: 6 givenname: Takashi surname: Misawa fullname: Misawa, Takashi – sequence: 7 givenname: Yosuke orcidid: 0000-0001-7521-4861 surname: Demizu fullname: Demizu, Yosuke |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33466998$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kl1rFTEQhhep2A_9Ad7IgjfeHJ18bZIbodavSkWheh2y2ckxh2xyutkt-O9Ne2ppK0gukkme92UyM4fNXsoJm-Y5gdeMaXgz5ohuiVhoBxQ454-aA8IprBhwvXfnvN8clrIBoIQT8aTZZ4x3ndbqoPnyHi8x5u2IaW6zb4_THMbgptwHG9vz2W4jDu133M5hwNK-s6WGObVf7dqGFFJL23O8WDA5fNo89jYWfHazHzU_P374cfJ5dfbt0-nJ8dnKCaHnFdWilxq8A2qZ9lpR6aDzvQSnOukZQemhB9kpoQlVwhIUXtuBcYeU-IEdNac73yHbjdlOYbTTb5NtMNcXeVobO83BRTSCM8Kcwn6Qineqt8oCSAJc9eic19Xr7c5ru_QjDq5WYbLxnun9lxR-mXW-NFIxqKsavLoxmHItQ5nNGIrDGG3CvBRDudScUsFpRV8-QDd5mVIt1TUlFNQGVerF3YxuU_nbsgqQHVCbVMqE_hYhYK7GwvwzFlUjH2hcmO0c8tWnQvyP8g_iuL5t |
CitedBy_id | crossref_primary_10_1016_j_bmcl_2024_129794 crossref_primary_10_1007_s00726_023_03245_w crossref_primary_10_1098_rsos_211583 crossref_primary_10_1002_psc_3551 crossref_primary_10_3390_antibiotics11101338 crossref_primary_10_3390_antibiotics11020273 crossref_primary_10_1248_yakushi_22_00115 crossref_primary_10_3390_antibiotics12010019 crossref_primary_10_3390_pharmaceutics13060773 crossref_primary_10_3390_ijms25169109 crossref_primary_10_1016_j_bpc_2022_106759 crossref_primary_10_1186_s40779_021_00343_2 crossref_primary_10_1039_D3DD00090G crossref_primary_10_1007_s10989_024_10623_9 crossref_primary_10_1007_s40495_023_00342_y crossref_primary_10_1016_j_drudis_2025_104305 crossref_primary_10_1016_j_ejmech_2025_117445 crossref_primary_10_1080_17460441_2024_2350568 crossref_primary_10_1016_j_phrs_2024_107137 crossref_primary_10_3390_antibiotics12081326 crossref_primary_10_1007_s00726_021_02995_9 crossref_primary_10_1016_j_biochi_2024_12_007 crossref_primary_10_1021_acsinfecdis_4c00115 crossref_primary_10_3390_pharmaceutics15031005 crossref_primary_10_37349_eds_2024_00041 crossref_primary_10_1021_acs_jcim_2c01419 crossref_primary_10_3390_mi14020373 crossref_primary_10_2139_ssrn_4174572 crossref_primary_10_1039_D3SC04124G crossref_primary_10_3390_biom11050761 crossref_primary_10_1021_acschembio_3c00411 crossref_primary_10_3390_cimb47010001 crossref_primary_10_3390_pharmaceutics16121542 crossref_primary_10_1016_j_ejmech_2023_115377 crossref_primary_10_3390_ijms22105364 crossref_primary_10_3390_antibiotics10121499 crossref_primary_10_3390_antibiotics12091400 crossref_primary_10_2174_0113892010194428231017051836 crossref_primary_10_36691_RJA15038 |
Cites_doi | 10.1146/annurev.biochem.78.082907.145923 10.1021/acsomega.9b01033 10.1038/srep01995 10.1016/j.csbj.2019.01.012 10.1038/35007145 10.1021/bc500408p 10.1021/acs.jmedchem.5b00537 10.1021/acs.jmedchem.9b02025 10.1016/j.bbamem.2006.02.032 10.1038/nchem.2779 10.1128/MMBR.00039-14 10.1039/C9MD00166B 10.1038/s41587-019-0222-z 10.1126/science.1099191 10.1021/acsabm.8b00835 10.1002/tcr.202000047 10.1039/C8AN00243F 10.1016/j.bpc.2015.02.005 10.1038/srep33003 10.1002/psc.2780 10.3390/ijms19103041 10.1002/cmdc.201900460 |
ContentType | Journal Article |
Copyright | 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
Copyright_xml | – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/molecules26020444 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
ExternalDocumentID | oai_doaj_org_article_54313c8ebd78468ba8a0071048beccf9 PMC7830303 33466998 10_3390_molecules26020444 |
Genre | Journal Article |
GrantInformation_xml | – fundername: the NOVARTIS Foundation (Japan) for the Promotion of Science grantid: Y.D. – fundername: TERUMO FOUNDATION for Life Sciences and ARTS grantid: Y.D. – fundername: the Sumitomo Foundation grantid: Y.D. – fundername: Japan Agency for Medical Research and Development grantid: 20mk0101120j0003 – fundername: Japan Society for the Promotion of Science grantid: 20k22711, H.Y.; 18k14880, T.M.; 17k08385 and 18H05502, Y.D. – fundername: Takeda Science foundation grantid: Y.D. – fundername: the Kobayashi Foundation for Cancer Research grantid: Y.D. – fundername: the Naito Foundation grantid: Y.D. |
GroupedDBID | --- 0R~ 123 2WC 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIWK ACPRK ACUHS AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EMOBN ESX FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE HZ~ I09 IAO IHR KQ8 LK8 M1P MODMG O-U O9- OK1 P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RPM SV3 TR2 TUS UKHRP ~8M 3V. ABJCF BBNVY BHPHI CGR CUY CVF ECM EIF HCIFZ KB. M7P M~E NPM PDBOC 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c559t-295b790fc02a39f9827c06fb70c867f31e7f0b0768591285a1e5f9ad34ce21fd3 |
IEDL.DBID | 7X7 |
ISSN | 1420-3049 |
IngestDate | Wed Aug 27 01:25:27 EDT 2025 Thu Aug 21 14:14:33 EDT 2025 Fri Jul 11 09:44:26 EDT 2025 Fri Jul 25 19:55:46 EDT 2025 Wed Feb 19 02:04:14 EST 2025 Thu Apr 24 23:09:07 EDT 2025 Tue Jul 01 01:17:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | stapled peptide amphipathicity antimicrobial peptides helical structure magainin 2 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c559t-295b790fc02a39f9827c06fb70c867f31e7f0b0768591285a1e5f9ad34ce21fd3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7521-4861 0000-0001-6523-0649 |
OpenAccessLink | https://www.proquest.com/docview/2479580002?pq-origsite=%requestingapplication% |
PMID | 33466998 |
PQID | 2479580002 |
PQPubID | 2032355 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_54313c8ebd78468ba8a0071048beccf9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7830303 proquest_miscellaneous_2479422542 proquest_journals_2479580002 pubmed_primary_33466998 crossref_primary_10_3390_molecules26020444 crossref_citationtrail_10_3390_molecules26020444 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20210116 |
PublicationDateYYYYMMDD | 2021-01-16 |
PublicationDate_xml | – month: 1 year: 2021 text: 20210116 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2021 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Li (ref_9) 2020; 63 Chang (ref_4) 2015; 79 Sekiya (ref_16) 2018; 143 Nikaido (ref_3) 2009; 78 Porter (ref_7) 2000; 404 Zweytick (ref_13) 2006; 1758 Saigo (ref_18) 2019; 4 Akishiba (ref_21) 2017; 9 Li (ref_2) 2015; 58 Strandberg (ref_20) 2015; 21 ref_1 Lin (ref_14) 2015; 26 Yokoo (ref_10) 2020; 20 Goto (ref_5) 2019; 14 Walensky (ref_6) 2004; 305 Mourtada (ref_11) 2019; 37 Krishnakumari (ref_12) 2015; 199 Sekiya (ref_17) 2019; 2 Misawa (ref_19) 2019; 10 Yamashita (ref_15) 2016; 6 Ali (ref_8) 2019; 7 Kawano (ref_22) 2013; 3 |
References_xml | – volume: 78 start-page: 119 year: 2009 ident: ref_3 article-title: Multidrug resistance in bacteria publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.biochem.78.082907.145923 – volume: 4 start-page: 13124 year: 2019 ident: ref_18 article-title: Electrophysiological analysis of antimicrobial peptides in diverse species publication-title: ACS Omega doi: 10.1021/acsomega.9b01033 – volume: 3 start-page: 1995 year: 2013 ident: ref_22 article-title: Automated parallel recordings of topologically identified single ion channels publication-title: Sci. Rep. doi: 10.1038/srep01995 – volume: 7 start-page: 263 year: 2019 ident: ref_8 article-title: Stapling peptides inhibitors: A new windows for target drug discovery publication-title: Comput. Struct. Biotechnol. J. doi: 10.1016/j.csbj.2019.01.012 – volume: 404 start-page: 565 year: 2000 ident: ref_7 article-title: Non-haemolytic-amino-acid oligomers publication-title: Nature doi: 10.1038/35007145 – volume: 26 start-page: 71 year: 2015 ident: ref_14 article-title: Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting publication-title: Bioconjug. Chem. doi: 10.1021/bc500408p – volume: 58 start-page: 4802 year: 2015 ident: ref_2 article-title: Helical Antimicrobial Sulfono-γ-AApeptides publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00537 – volume: 63 start-page: 4081 year: 2020 ident: ref_9 article-title: Novel stapling by lysin tethering provides stable and low hemolytic cationic antimicrobial peptides publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.9b02025 – volume: 1758 start-page: 1426 year: 2006 ident: ref_13 article-title: Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity publication-title: Biochim. Biophys. Acta. doi: 10.1016/j.bbamem.2006.02.032 – volume: 9 start-page: 751 year: 2017 ident: ref_21 article-title: Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide publication-title: Nat. Chem. doi: 10.1038/nchem.2779 – volume: 79 start-page: 101 year: 2015 ident: ref_4 article-title: Origin and Proliferation of multi-drug resistance in Bacterial pathogen publication-title: Microbiol. Biol. Rev. doi: 10.1128/MMBR.00039-14 – volume: 10 start-page: 896 year: 2019 ident: ref_19 article-title: Rational design of novel amphipathic antimicrobial peptides focused on distribution of cationic acid residues publication-title: MedChemComm. doi: 10.1039/C9MD00166B – volume: 37 start-page: 1186 year: 2019 ident: ref_11 article-title: Design of stapled antimicrobial peptides that are stable, nontoxic, and kill antibiotic-resistant bacteria in mice publication-title: Nat. Biotechnol. doi: 10.1038/s41587-019-0222-z – volume: 305 start-page: 1466 year: 2004 ident: ref_6 article-title: Activation of apoptosis in Vivo by a hydrocarbon stapled BH3 Helix publication-title: Science doi: 10.1126/science.1099191 – volume: 2 start-page: 1542 year: 2019 ident: ref_17 article-title: Electrophysiological analysis of membrane disruption by bombinin and its isomer using the lipid bilayer system publication-title: ACS Appl. Bio Mater. doi: 10.1021/acsabm.8b00835 – volume: 20 start-page: 912 year: 2020 ident: ref_10 article-title: De Novo design of cel-penetrating foldamers publication-title: Chem. Rec. doi: 10.1002/tcr.202000047 – volume: 143 start-page: 3540 year: 2018 ident: ref_16 article-title: Channel current analysis estimates the pore-formation and the penetration of transmembrane peptides publication-title: Analyst doi: 10.1039/C8AN00243F – volume: 199 start-page: 25 year: 2015 ident: ref_12 article-title: N-Terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine -defensin-2 results in salt-resistant antibacterial activity publication-title: Biophys. Chem. doi: 10.1016/j.bpc.2015.02.005 – volume: 6 start-page: 33003 year: 2016 ident: ref_15 article-title: Development of a cell-penetrating peptide that exhibits responsive changes in its secondary structure in the cellular environment publication-title: Sci. Rep. doi: 10.1038/srep33003 – volume: 21 start-page: 436 year: 2015 ident: ref_20 article-title: Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa publication-title: J. Pept. Sci. doi: 10.1002/psc.2780 – ident: ref_1 doi: 10.3390/ijms19103041 – volume: 14 start-page: 1911 year: 2019 ident: ref_5 article-title: Development of amphipathic antimicrobial peptide foldamers based on Magainin 2 sequence publication-title: ChemMedChem doi: 10.1002/cmdc.201900460 |
SSID | ssj0021415 |
Score | 2.485338 |
Snippet | Magainin 2 (Mag2), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial... Magainin 2 ( ), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial activity... Magainin 2 ( Mag2 ), which was isolated from the skin of the African clawed frog, is a representative antimicrobial peptide (AMP) that exerts antimicrobial... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 444 |
SubjectTerms | Amino Acid Sequence Amino acids amphipathicity Animals Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antimicrobial agents antimicrobial peptides Aqueous solutions Bacteria Chromatography Cytotoxicity Drug resistance Enzymes Gram-negative bacteria Gram-Negative Bacteria - growth & development Gram-Positive Bacteria - growth & development helical structure Hydrocarbons magainin 2 Magainins - chemistry Magainins - pharmacology Membranes Peptides stapled peptide Xenopus laevis Xenopus Proteins - chemistry Xenopus Proteins - pharmacology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9swEBajL93LaLut9ZoWDfZUMJX1W49NaCiFlsFW6JuxZIkFEics6f_fO9sJSTval70Z64Tlu7O_O3T6jpAfIWokbXF5TAXPpUky90nGXHgVldPGiIDnne_u9c2DvH1Uj1utvrAmrKMH7hR3iWe1RbDR1wag0vrKVi0sSotPT-3RPcC8dTLVp1oF4FK3hykgqb-cda1m4xKid44MaTso1JL1_yvCfFkouYU84wPyqQ8Z6VW31EPyITZHZH-07tT2mdxuVf7QeaJXzWoym7QMSzAPwsnFNNb0J9av1HFJhwBcNZ03FMmlsT8E5fRXX1H9hTyMr3-PbvK-R0IeIBdY5dwpbxxLgfFKuOQsN4Hp5A0LVpskimgS87jdphxAkaqKqJKraiFD5EWqxVey18ybeEKo0lW0TDMHMYwEhXsPF3WCEDxpb3SVEbbWWRl6AnHsYzEtIZFANZev1JyRi82URcee8ZbwEA2xEUTi6_YGuEPZu0P5njtkZLA2Y9l_jcuSS-OUxZ9_Rr5vhsFIuDlSNXH-1MlI-LlJkDnurL5ZiRBSa8hLM2J2_GFnqbsjzeRPy9VtLMQITHz7H-92Sj5yrKhh2Np7QPZWf5_iGYREK3_eev8zJk4LbA priority: 102 providerName: Directory of Open Access Journals |
Title | Development of Antimicrobial Stapled Peptides Based on Magainin 2 Sequence |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33466998 https://www.proquest.com/docview/2479580002 https://www.proquest.com/docview/2479422542 https://pubmed.ncbi.nlm.nih.gov/PMC7830303 https://doaj.org/article/54313c8ebd78468ba8a0071048beccf9 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtcmgvJenTabKo0FPBRLbep5IN2YZAQ2gb2JuxZKldSOxtdvP_M2NrN9m05GKMJYPQjDTfaEbfEPLZB4WkLTYPsShzoaPIXRQh504GaZXW3ON95-_n6vRSnE3lNB24LVJa5WpP7DfqpvN4Rn5YCm2lwQX8df43x6pRGF1NJTSek22kLkOt1tN7h6sA6zREMjm49ofXQ8HZsAAMXyJP2oYt6in7_4czH6dLPrA_kx3yKgFHejRIepc8C-1r8uJ4Va_tDTl7kP9Du0iP2uXsetbzLMF_ACrnV6GhF5jF0oQFHYP5amjXUqSYxioRtKQ_U171W3I5Ofl1fJqnSgm5B49gmZdWOm1Z9KysuY3WlNozFZ1m3igdeRF0ZA6DbtKCQZJ1EWS0dcOFD2URG_6ObLVdGz4QKlUdDFPMApIRJjjn4KWJAMSjclrVGWGrOat8ohHHahZXFbgTOM3VP9OckS_rX-YDh8ZTnccoiHVHpL_uP3Q3v6u0miq8wM89jK7RgJ-Mq03dYyVhUCWjzcj-SoxVWpOL6l6DMvJp3QxCwhBJ3YbudugjYIsT0Of9IPX1SDgXSoF3mhG9oQ8bQ91saWd_esZubQApML739LA-kpclZswwLN29T7aWN7fhACDP0o16vYanmXwbke3xyfnFj1F_fHAH4zUGQQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VcigXxJtAASPBBSmqYzt2fECoLSzbp5Bopd5CnNiwUpss3a0Qf4rfyEweSxdQb71FsR1ZnvHMN_H4G4BXpddE2mJjHxIRKxNU7ILysXSpT602RpZ03_ngUI-P1e5JerICv4a7MJRWOdjE1lBXTUn_yDeEMjbNaAO_m36PqWoUna4OJTQ6tdjzP39gyDZ7u_Me5ftaiNGHo-1x3FcViEtEz_NY2NQZy0PJRSFtsJkwJdfBGV5m2gSZeBO4owOq1KLxTovEp8EWlVSlF0moJH73BtxUEj053UwffVwEeAl6w-7kFBv5xllX4NbPMGYQxMu25PvaEgH_w7V_p2de8nejO3C7B6pss9Osu7Di63uwtj3Uh7sPu5fyjVgT2GY9n5xNWl4nHIcgdnrqK_aJsmYqP2Nb6C4r1tSMKK2pKgUT7HOfx_0Ajq9lDR_Cat3U_jGwVBc-45pbRE4q8845fKgCAv-gndFFBHxYs7zsacupesZpjuELLXP-zzJH8GYxZNpxdlzVeYsEsehIdNvti-b8a97v3pwIA2SJs6sM4rXMFVnRYjOV0RYINoL1QYx5bwNm-R-NjeDlohmFREcyRe2bi66PQpOqsM-jTuqLmUiptMZoOAKzpA9LU11uqSffWoZwkyEy4fLJ1dN6AWvjo4P9fH_ncO8p3BKUrcOpbPg6rM7PL_wzhFtz97zVcQZfrntT_QYyhz7m |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IO4UBhgJXpCiurZjxw8IrbtoF6gqYNLesjixodKWlLUT4q_x6zgnl7IC2tveosaJLJ-Lv1OffB_A69xrIm2xkQ9DESkTVOSC8pF0sY-tNkbm9L3zx7HeO1IHx_HxGvzqvoWhtsouJ9aJuqhy-o98IJSxcUIBPAhtW8Rke_f97HtEClJ00trJaTQucuh__sDybf5ufxtt_UaI3Z0vW3tRqzAQ5YikF5GwsTOWh5yLTNpgE2FyroMzPE-0CXLoTeCODqtii4k8zoY-DjYrpMq9GIZC4ntvwLqhqqgH66Od8eTTstwb4t7YnKNKafngrJG79XOsIASxtK3shLVgwP9Q7t_Nmpd2v927cKeFrWyz8bN7sObL-3Brq1OLewAHl7qPWBXYZrmYnk1rlid8DiHt7NQXbEI9NIWfsxFungWrSkYE16RRwQT73HZ1P4Sja1nFR9Arq9I_ARbrzCdcc4s4SiXeOYcXRcAyIGhndNYH3q1Zmrck5qSlcZpiMUPLnP6zzH14u3xk1jB4XDV4RIZYDiTy7fqH6vxr2sZySvQBMsfZFQbRW-KyJKuRmkooIILtw0ZnxrTNCPP0j__24dXyNhqJDmiy0lcXzRiFCVbhmMeN1ZczkVJpjbVxH8yKP6xMdfVOOf1W84WbBHEKl0-vntZLuIkBlX7YHx8-g9uCWnc4aYhvQG9xfuGfI_ZauBetkzM4ue64-g0x30R4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Antimicrobial+Stapled+Peptides+Based+on+Magainin+2+Sequence&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Hirano%2C+Motoharu&rft.au=Saito%2C+Chihiro&rft.au=Yokoo%2C+Hidetomo&rft.au=Goto%2C+Chihiro&rft.date=2021-01-16&rft.issn=1420-3049&rft.eissn=1420-3049&rft.volume=26&rft.issue=2&rft_id=info:doi/10.3390%2Fmolecules26020444&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |